Could oral hypoglycemics be the new therapeutic answer to chronic obstructive pulmonary disease?
Man
S F Paul
SF
Sin
Don D
DD
D000284:Administration, Oral; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008687:Metformin / Q000494:pharmacology / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D012720:Severity of Illness Index; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D008687:Metformin